Samlyn Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.4M Buy
+117,407
New +$27.1M 0.46% 57
2013
Q3
– Sell
-637,800
Closed -$38.7M – 97
2013
Q2
$38.7M Buy
+637,800
New +$38M 1.13% 38

Other funds holding DGX

Samlyn Capital's DGX Position: Q3 2026 in Review

Samlyn Capital opened a new position in Quest Diagnostics (DGX) in Q3 2026: 117,407 shares worth $27.4M. The stake represents 0.46% of the portfolio and ranks #57 among its holdings. This is a return to the name: Samlyn Capital previously reported a position in DGX as recently as Q2 2013.

Samlyn Capital first reported a position in DGX in Q2 2013 and has held it in 2 quarters since. The position peaked at $38.7M in Q2 2013. 1,109 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Samlyn Capital held 117,407 shares of Quest Diagnostics worth $27.4M as of Q3 2026.
  • Quest Diagnostics was a new Samlyn Capital position in Q3 2026.
  • Quest Diagnostics made up 0.46% of Samlyn Capital's portfolio in Q3 2026, its #57 holding.
  • Samlyn Capital first reported a position in Quest Diagnostics in Q2 2013 and has held it in 2 quarters since.
  • Samlyn Capital's Quest Diagnostics position peaked at $38.7M in Q2 2013.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Samlyn Capital's 13F filing for Q3 2026, filed 16 Nov 2026.